6/29/2010

An FDA committee will hold a two-day public hearing this week to discuss strategies that would encourage drugmakers to develop treatments for rare diseases. The meeting comes after the FDA released a list of approved medicines that could be used for orphan-drug research.

Full Story:
Reuters

Related Summaries